Vimarsana
Biggest News Aggregation in the World

Page 2 - Innovative Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Innovative Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Innovative Sciences Today - Breaking & Trending Today

High-Quality Phase I-IV Clinical Trial Conduct - Vimarsana News

High-Quality Phase I-IV Clinical Trial Conduct

/PRNewswire/ -- Apex Innovative Sciences ("Apex" or the "Company"), a leading provider of clinical development and trial site services, is pleased to announce...

New material avoids AR/VR glasses 'bug eyes' - Vimarsana News

New material avoids AR/VR glasses 'bug eyes'

Researchers have come up with a new technology to deliver augmented and virtual reality glasses that don’t look like “bug eyes.” “Image” is everything in the $20 billion market for AR/VR glasses. Consumers are looking for glasses that are compact and easy to wear, delivering high-quality imagery with socially acceptable optics. In a new paper in Science Advances, researchers describe imprinting freeform optics with a nanophotonic optical element called “a metasurface.” The metasurface is a veritable forest of tiny, silver, nanoscale structures on a thin metallic film that confo...

BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a ... - Vimarsana News

BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a ... BioXcel TherapeuticsFebruary 12, 2021 GMT NEW HAVEN, Conn., Feb. 12, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that the Company will host a virtual Key Opinion Leader (“K...

Source: apnews.com